Listing ID #7370915
Company Information
Ask for more detail from the seller
Contact Supplier
Pamorelin LA 11.25 mg Injection belongs to the class of 'anti-neoplastic agents', primarily used to treat prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Prostate cancer is the prostate gland's cancer (a small gland under the bladder secretes fluid that nourishes and protects sperm) found only in men. Endometriosis is a disorder in which tissue lining the uterus grows outside the uterine cavity. Precocious puberty occurs when a child's body changes into that of an adult or experiences puberty too soon.
Pamorelin LA 11.25 mg Injection contains Triptorelin that belongs to the class of gonadotropin-releasing hormone (GnRH) agonists. Triptorelin is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. It works by inhibiting the synthesis of the natural male hormone, testosterone in men and oestrogen in women. The lowering of testosterone hormone levels in men helps slows down the growth of cancer cells in prostate cancer.
Use Pamorelin LA 11.25 mg Injection as prescribed by your doctor. Your doctor will decide the dosage depending on your medical condition. The common side effects of Pamorelin LA 11.25 mg Injection include hot flashes, decreased sexual interest, shrinking of the testicles, breast tenderness or swelling, dizziness, headache, flu symptoms, nausea, vomiting, diarrhoea, upset stomach and swelling in legs. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Do not take or stop this medicine, if the doctor did not advise you to do so. Before starting Pamorelin LA 11.25 mg Injection, let your doctor know if you have any medical history of liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Pamorelin LA 11.25 mg Injection is not indicated for use in pregnant and breastfeeding women. Pamorelin LA 11.25 mg Injection may make you feel dizzy, hence drive when you are alert only. Pamorelin LA 11.25 mg Injection is not recommended for children below two years of age.
Prisha Pharmaceutical Distributors was established in the year 2022 in Maharashtra, India. We are an exporter and importer of pharmaceutical vaccines, oncology medicines and a lot more. We have set up a state-of-the-art infrastructural facility, which enables us to serve the clients timely in an appropriate manner.
Â
We have a spacious warehouse, packaging, quality testing, research labs and other allied units. These units are headed by skilled staff having sound industrial knowledge. We upgrade the technology used in our processes at regular intervals, to cope with the ever-changing market trends.
Â
Various factors contribute to our success and long-term survival, but our customer-friendly policies play a prominent role at large. We always believe in serving the clients in the way they want, which has helped us to muster a huge clientele, by winning their trust. With the help of a vast distribution network, we ensure timely deliveries to customer’s doorsteps even in the remotest part of the nation.
Â
Our Quality
Â
The prime aim of our firm is to serve clients with the best quality products, hence we keep a close vigil on all the involved processes related to production. Various pre and post-production processes are cross-checked by the quality controllers, to reduce the chances of flaws and errors and to make the final range up-to-the-mark.
Nature of Business
Exporter / Supplier / Retailer / Distributor / Importer / Trader
Number of Employees
Below 20
Year of Establishment
2022
Mecoson Labs
Connect with us
For Buyer 
For Seller 
Help 
